Migraine, a recurring headache disorder manifesting in attacks lasting 4 h to 72 h ([@b1-prm-20-e1]) and affecting 2% to 15% of the world's population ([@b2-prm-20-e1]) with an estimated one-year prevalence of 16.4% in Turkey ([@b3-prm-20-e1]), has been associated with significant individual and societal burdens related to disability and productivity loss ([@b1-prm-20-e1],[@b4-prm-20-e1]).

The most common form of migraine -- migraine without aura (MwoA) -- is experienced by the large majority of migraineurs ([@b5-prm-20-e1]), with an incidence ranging from 1.37 to 10.1 per 1000 person-years among men and 2.9 to 18.9 per 1000 person-years among women ([@b6-prm-20-e1]). However, despite being a common disorder frequently encountered in clinical practice, migraine is frequently underdiagnosed and misdiagnosed ([@b7-prm-20-e1],[@b8-prm-20-e1]).

In 2004, the International Headache Society published the second edition of the International Classification of Headache Disorders (ICHD-II) aiming to standardize scattered headache terminology ([@b9-prm-20-e1]). Concerning MwoA, similar to the second edition (ICHD-II), the ICHD-III beta version did not introduce major changes to its predecessor, published in 1998 (ICHD-I) ([@b9-prm-20-e1]--[@b11-prm-20-e1]). ICHD-III beta requires five criteria to diagnose MwoA in an adult including unilateral pain location with throbbing quality, severe intensity, presence of nausea/vomiting and/or photophobia/phonophobia, and a duration of 4 h to 72 h ([@b11-prm-20-e1]). However, many patients continue to face difficulties in fulfilling the overall criteria in ICHD-III beta to be diagnosed with MwoA, and it appears to be reasonable to classify them in what may be referred to as a 'grey zone'.

Indeed, the criteria included in the original and updated second edition of ICHD were primarily developed to standardize the diagnosis of migraine headache within clinical research trials ([@b12-prm-20-e1]). It is possible that the complexity of the proposed criteria represents a significant barrier to their use as a diagnostic tool by primary care physicians in routine clinical practice ([@b12-prm-20-e1]). As a result of the considerable gap between the practices of researchers and clinicians ([@b9-prm-20-e1],[@b13-prm-20-e1]), and the adoption of ICHD diagnostic criteria for migraine in a limited manner in clinical practice ([@b12-prm-20-e1]), there are variable data and limited statistical evaluations regarding the characteristics of migraine. Consideration needs to be given to the sensitivity and specificity of the items included in the diagnostic criteria for migraine in the literature ([@b14-prm-20-e1]).

Although the ICHD-III beta version ([@b11-prm-20-e1]) made no significant contribution to MWoA criteria in terms of novelty, following the publication of this version, the ICHD-III beta coordinator, Dr Jes Olesen, has issued a call to clinicians and researchers to submit feedback of their practical experiences and field studies based on their criteria. After this feedback, the category will take its final shape before publishing. In our daily clinical practice, we have encountered several patients who fail to meet the diagnostic criteria, despite being considered to have MwoA in a clinical sense. The present study aimed to clarify some of the issues related to the classification of disease in clinical practice and contribute to the data available on field trials of the ICHD-III beta version.

The present study was designed to retrospectively evaluate the clinical dataset (derived from the Turkish Headache Database) available for patients with MwoA, who were being followed at a tertiary care centre, to determine the diagnostic value of clinical characteristics included in the ICHD-III beta-based diagnostic criteria of MwoA in relation to grey zones in the diagnosis; in addition, we sought to determine potential covariates of a 'possible MwoA'.

METHODS
=======

Subjects
--------

From the initial dataset of 3286 patients with migraine, after excluding those with 'possible' diagnosis, known comorbidities and missed clinical variables, a total of 1365 patients diagnosed with MwoA according to the criteria of the ICHD-III beta ([@b11-prm-20-e1]) during their follow-up by the Headache Outpatient Clinic of the Neurology Department of Mersin University School of Medicine (Mersin, Turkey) were included in the present tertiary care-based, retrospective clinical study. Excluded patients were as follows: 619 patients had 'possible MwoA' diagnosis; 423 patients had migraine and tension-type headache, or other primary or secondary causes of headache disorders; and 879 patients had missing clinical variables.

The inclusion criterion was a history of ≥5 migraine attacks. Patients who had medication-overuse headache, pure menstrual migraine or any other associated headache disorder were excluded from the study. In addition, 'advanced' cardiac, respiratory, renal or hepatic diseases; malignancy; major psychiatric disorders or a history of drug/alcohol abuse; and pregnancy before or during the study were considered to be exclusion criteria.

Permission was obtained from the authors' institutional ethics committee for the use of patient data for publication purposes (MEU.0.01.00.06/265, 20.10.2008).

Diagnostic classification of MwoA
---------------------------------

The diagnosis of MwoA was made in accordance with the criteria of the ICHD-III beta (International Headache Society 1.1., *International Classification of Diseases, 10th revision*, G43.0) ([@b11-prm-20-e1]) ([Table 1](#t1-prm-20-e1){ref-type="table"}), based on a history of ≥5 attacks lasting 4 h to 72 h (untreated or unsuccessfully treated), showing at least two of the following characteristics: unilateral location, pulsating quality, moderate or severe pain intensity, and aggravation by or causing avoidance of routine physical activity (eg, walking or climbing stairs), accompanied by at least one of the following during headache: nausea and/or vomiting, photophobia and phonophobia, none of which were attributed to another disorder. The patients meeting all of the criteria of the ICHD-III beta -- ie, experiencing attacks lasting 4 h to 72 h and characterized by a visual analogue scale (VAS) score ≥5 (the midpoint of a zero to 10 VAS), pulsating quality, unilateral location and concomitant nausea and/or vomiting along with photophobia and phonophobia -- were classified as having full MwoA.

In addition, cases failing to fulfill only one of the basic diagnostic criteria for migraine, but whose migraine diagnosis was supported by the specialist in clinical terms were classified as zone I; cases failing to fulfill two of the basic diagnostic criteria for migraine, but whose migraine diagnosis was supported by the specialist in clinical terms were classified as zone II; and cases failing to fulfill three of the basic diagnostic criteria for migraine, but whose migraine diagnosis was supported by the specialist in clinical terms were classified as zone III.

Assessments
-----------

The diagnostic value of the clinical characteristics included among the ICHD-II-based diagnostic criteria of MwoA was evaluated with respect to the diagnostic classification of patients as full MwoA, and the grey zones I to III.

The role of sex and covariates in the diagnosis of full MwoA, zone 1, zone II and zone III classifications were evaluated via univariate analysis. Patients in each diagnostic classification were compared in terms of sex distribution and the presence of covariates, including motion sickness, periodic vomiting, abdominal pain, allergy, infantile colic, premature birth, emotional distress, physical activity, factors related to the menstrual cycle, seasonal factors, fasting, dizziness, sleep irregularities, vertigo, osmophobia and allodynia, as well as the duration of pain.

The significance of the covariates in each diagnostic classification was ranked via multiple logistic regression analysis for the variables determined to be associated with a significance of ≤0.20 in the univariate analysis.

Statistical analysis
--------------------

Regression analysis was performed with the variables determined to be associated with a significance of ≤0.20 in the univariate analysis. Predictors with a possible influence on a dependent variable were added as covariates. Data were expressed as mean ± SD, percent and median. Statistical analysis was conducted using SPSS version 13.0 (IBM Corporation, USA). The predictive role of the clinical characteristics of migraine considered among the diagnostic criteria of MwoA, together with the role of sex and covariates in the diagnosis of full MwoA, zone 1, zone II and zone III, was evaluated via univariate analysis. The significance of covariates was ranked via regression analysis and OR, 95% CI where appropriate. P\<0.05 was considered to be statistically significant.

RESULTS
=======

The diagnostic values of the clinical characteristics are included in the ICHD-III beta based diagnostic criteria. Of 1365 patients (mean \[± SD\] age 38.5±10.4 years \[range 18 to 75 years\], 88.2% women), the mean headache duration was 7.01±6.56 h, frequency was 8.83±8.67 days per month and severity was 7.09±1.93 according to VAS. When the history of the patients was evaluated, periodic vomiting was observed in 22.7% of the patients, recurrent abdominal pain in 27.2%, motion sickness in 58.6% and atopic disorders in 53.9%. When the triggering factors were observed, emotional stress was detected in 91.3% of patients, and factors related to the menstrual cycle in 64.2%. A total of 77.3% of the patients stated that their pain was exacerbated by routine physical activity. Among the pain-related findings, nausea was detected in 98.3% of patients, vomiting in 70.6%, phonophobia in 91.9% and photophobia in 83.5%.

Only 351 (25.7%) patients were classified as having full MwoA. However, 546 (40.0%) patients were classified as zone I, 327 (24.0%) patients as zone II and 141 (10.3%) as zone III, according to the criteria mentioned above.

MWoA
----

A total of 351 patients fulfilled all the MwoA diagnostic criteria; this was confirmed using the ICHD-III beta. Ninety percent of these patients were female ([Table 2](#t2-prm-20-e1){ref-type="table"}). These patients constituted the largest group in terms of a history of periodic vomiting (24.1%) and of abdominal pain that was not associated with any other cause (34.5%) ([Table 3](#t3-prm-20-e1){ref-type="table"}). In this group, the most common triggering factor was emotional distress (98.0%) ([Table 4](#t4-prm-20-e1){ref-type="table"}). Motion sickness (57.8%), osmophobia (76.9%) and sleep irregularities (76.4%), which are not included among the factors related to migraine in the diagnostic criteria, were found to be significantly associated with MWoA ([Table 5](#t5-prm-20-e1){ref-type="table"}). Among the variables studied, in terms of covariate factors, sleep irregularities in men (OR 1.596) and periodic vomiting in women (OR 1.464) were the 'most important' (first degree) variables (P\<0.05). Osmophobia (OR 1.348) and motion sickness (OR 1.237) were second-degree variables; these symptoms were more distinct in men. Third-degree variables in full MwoA included emotional distress (OR 1.263), abdominal pain (OR 1.083), allodynia (OR 0.647) and dizziness (OR 1.045); these were also more commonly observed in male patients compared with female patients. Allergy, infantile colic, heavy physical activity, vertigo, menstrual factors, seasonal factors and fasting had a negligible effect on the state of full MwoA ([Table 6](#t6-prm-20-e1){ref-type="table"}).

Zone I
------

There were 546 patients (40.0%) who failed to fulfill only one of the standard diagnostic criteria (zone I); they formed the largest group of all the groups studied. In this group, it was notable that at least one of the characteristics, except for the pain level, was missing in at least one of the patients at varying rates (30% to 90.1%). The least commonly observed characteristic was unilateral localization of the pain (30.8%; OR 0.431; P\<0.001) ([Table 2](#t2-prm-20-e1){ref-type="table"}). A history of infantile colic was significantly higher in zone I patients (12.8%; P=0.041) ([Table 3](#t3-prm-20-e1){ref-type="table"}). The prominent triggering factor in the group was menstruation (58.1%; P=0.050) ([Table 4](#t4-prm-20-e1){ref-type="table"}). Among the factors associated with migraine, dizziness (69.0%; P\<0.001) became increasingly prevalent ([Table 5](#t5-prm-20-e1){ref-type="table"}). When observed in terms of covariates, the most effective variable for women in zone 1 was a history of infantile colic (OR 5.111). The second most effective variable of the group as a whole was menstrual triggering (OR 1.669), while third among the effective variables were a history of pain-associated dizziness (OR 1.299) and accompanying sleep irregularity (OR 0.839). A history of accompanying atopic disorder (OR 0.931) and osmophobia (OR 1.027) were the fourth most effective variables. The effect of other covariates in the relevant patient group was negligible ([Table 6](#t6-prm-20-e1){ref-type="table"}).

Zone II
-------

There were 327 (24.0%) patients who did not meet two of the standard diagnostic criteria (zone II); all variables, except for the pain level and accompanying photophobia and/or phonophobia, showed a diagnostic effect ([Table 2](#t2-prm-20-e1){ref-type="table"}). In this group's history, no significant variable was detected ([Table 3](#t3-prm-20-e1){ref-type="table"}), nor were any meaningful risk factors and accompanying symptoms detected ([Tables 4](#t4-prm-20-e1){ref-type="table"} and [5](#t5-prm-20-e1){ref-type="table"}). When assessed in terms of covariate factors, the most effective variable for these patients was the presence of accompanying sleep irregularities in women (OR 0.732). The second most effective variables for patients of both sexes were a history of abdominal pain (OR 0.742), and accompanying dizziness (OR 0.864) or osmophobia (OR 0.863). The third most effective variables were accompanying atopic disorders (OR 0.918) or a history of motion sickness (OR 1.106). The accompanying allodynia (OR 0.983) was the least effective variable, while the effect of other variables was negligible ([Table 6](#t6-prm-20-e1){ref-type="table"}).

Zone III
--------

There were 141 patients (10.3%) who did not fulfill ≥3 of the standard diagnosis criteria although they were diagnosed as MwoA in clinical terms. In this group, the diagnostic criteria were statistically significant ([Table 2](#t2-prm-20-e1){ref-type="table"}). However, no single triggering factor or accompanying symptom in the patients' history was prominent ([Tables 3](#t3-prm-20-e1){ref-type="table"} to [5](#t5-prm-20-e1){ref-type="table"}). When the diagnostic values of the covariates of this group were observed, the most meaningful clinical characteristics were accompanying osmophobia (OR 0.385) for men and sleep irregularities (OR 0.642) for women. The second most effective variables, regardless of sex, were a history of periodic vomiting (OR 0.592) or recurrent abdominal pain (OR 0.584), and associated dizziness (OR 0.793) or allodynia (OR 1.290). While a history of accompanying motion sickness (OR 1.188) or vertigo (OR 1.137) was the third most effective feature, menstrual triggering (OR 0.995) was the fourth most effective. The effect of the other covariates was negligible ([Table 6](#t6-prm-20-e1){ref-type="table"}).

When all the variables were evaluated together, the diagnostic order of covariates for full MwoA diagnosis was as follows: associated sleep dysregulation, a history of periodic vomiting, associated osmophobia, motion sickness, triggered emotional stress, recurrent abdominal pain and a history of atopic disorders ([Figure 1](#f1-prm-20-e1){ref-type="fig"}).

DISCUSSION
==========

The present study involved the retrospective evaluation of patients diagnosed with MwoA by a headache specialist using a semistructured headache database system. In terms of the diagnostic value of the clinical characteristics included among the ICHD-III beta-based diagnostic criteria, it was revealed that only 25.7% of patients were categorized as full MwoA, while 74.3% failed to fulfill ICHD/ICHD-III beta-based diagnostic criteria and were, thus, categorized in three grey zones: I (40.0%), II (24.0%) and III (10.3%). The severity of the headache and presence of photophobia and/or phonophobia were the best diagnostic items evident in the greatest number of patients, regardless of their classification, whereas unilateral location and pulsating quality were significantly less common in the grey zones.

When a patient meets all criteria except one, migraine is classified as migrainous disorder in ICHD I (1988) ([@b10-prm-20-e1]) and probable migraine in ICHD II (2004) ([@b9-prm-20-e1]). A study involving a critical analysis of ICHD I (1988) and ICHD II (2004) for migraine in children and adolescents reported that 57% of the cases were diagnosed as migrainous disorder and 30% as probable migraine ([@b15-prm-20-e1]).

The rationale for performing the present study was that in daily practice, we, as physicians abiding by the ICHD classification, encounter many patients who do not fulfill all the criteria, but for whom inclusion in the class of 'possible' sufferers is not the solution. As also revealed by the present data set, the full MwoA group constituted only one of four (25.7%) cases diagnosed with MwoA by the clinician, and this was merely the 'tip of the iceberg'. We aimed to identify the covariates determining the remaining cases and, perhaps, make some contribution to the committee, in particular at a time when we are discussing the final version of ICHD-III and its class criteria.

The full MwoA group revealed the importance of a history of recurrent abdominal pain and periodic vomiting, in addition to other previously known characteristics of migraine. Motion sickness, osmophobia and associated sleep irregularities, which are also observed in a high proportion of these patients, do not appear among the diagnostic criteria in the ICHD-III beta version, but are covariates that are should be taken into consideration. Of these characteristics, some (sleep irregularities and periodic vomiting) were more important in women, while others (osmophobia and motion sickness) applied more to men. To the best of our knowledge, the present study was the first to analyze the diagnostic criteria of headache in the context of group covariate analysis, particularly using a large database. In the literature, excessive daytime sleepiness, difficulty initiating and maintaining sleep, early morning awakening and daytime fatigue ([@b16-prm-20-e1]) were reported as the most commonly encountered sleep disturbances among migraineurs, with negative impact on their quality of life and a higher rate of morbidity ([@b17-prm-20-e1]). Given that patients with MwoA have a much higher prevalence of sleep abnormalities than control patients, possibly due to multiple contributory factors ([@b17-prm-20-e1]), our finding that sleep irregularities are first-rank determinants of the migraineurs with full MwoA diagnosis is notable. However, we could not identify evidence of sleep irregularities having sex-related diagnostic significance in the literature.

Osmophobia characterized by hyperosmia combined with avoidant behaviours and functional impairment is a rare, specific phobic disorder, although commonly observed in patients with migraine ([@b18-prm-20-e1]). In correlation to its identification as a second-degree determinant of full MwoA in our study population, osmophobia has been considered to be an important clinical feature of the headache pattern closely associated with migraine, not only because it is significantly more frequent in migraineurs but also because it has an important prognostic value ([@b19-prm-20-e1]).

Similarly, two important diagnostic features that should be discussed are previous periodic vomiting and recurrent abdominal pain. Patients with cyclic vomiting were reported to have a higher incidence of migraine than the general population (22% and 5%, respectively) ([@b20-prm-20-e1],[@b21-prm-20-e1]), while a higher prevalence of colic (29% versus 11%) was reported in the infants of migraineur mothers ([@b22-prm-20-e1]). However, while these characteristics are explained in the classification as supportive characteristics, no satisfying explanation on their diagnostic importance has been offered, except for periodical symptoms. In our analyses, these covariates, coming to the forefront particularly among women, deserve to be rediscussed as diagnostic characteristics.

Analysis of cases in zone I, the largest group, revealed that the diagnosis of 40% of the patients may change if the diagnostic criteria are reviewed. In this group, we observed that a history of infantile colic with associated dizziness and a medical history of atopic disorder were present to a marked degree, and that menstrual triggering was also important in women. The predictive role of both cyclic vomiting ([@b23-prm-20-e1]) and infantile colic ([@b22-prm-20-e1],[@b24-prm-20-e1]) in MwoA diagnosis in our study population supports the fact that they have commonly been considered to be precursors to migraine. Symptoms of dizziness or vertigo were reported in 54% and motion sickness, the most common vestibular symptom, in more than one-half of patients with migraine, with increased susceptibility to motion sickness among migraineurs ([@b25-prm-20-e1]). At the same time, the diagnostic importance of the migraine-atopy association and accompanying dizziness/vertigo or motion sickness was emphasized in our previous studies ([@b26-prm-20-e1],[@b27-prm-20-e1]). The analysis of the present dataset once again verifies the previous clinical study data.

Pain level was an important determinant in zone II. Covariates matched up with the previous zones. Sleep irregularities were observed to be an important covariate, particularly among women, supporting the increasing interest in recent years in sleep irregularities accompanying migraine patients ([@b8-prm-20-e1],[@b16-prm-20-e1],[@b19-prm-20-e1]). We believe that more research should be conducted on the subject.

No different diagnostic characteristic stood out in zone III; ie, this was the zone closest to the spectrum's 'possible' end. We wish to emphasize here that vertigo accompanying headache attacks, although not having a coefficient as highly significant as dizziness, is a relatively rarely discussed characteristic in the literature, notwithstanding its appearance in our previous clinical studies ([@b27-prm-20-e1]). In this group, allodynia was found to be the second most important variable. Allodynia is defined as the perception of pain in response to normal activities, such as shaving, showering or wearing jewelry, and is reported in 63% to 79% of migraineurs ([@b28-prm-20-e1]), while severe pain was associated with a higher number of triggers in migraineurs ([@b29-prm-20-e1]). Given the likely role of allodynia in migraine transformation, lowering the migraine-attack threshold and, thus, facilitating an increase in headache frequency ([@b30-prm-20-e1]), it appears notable that allodynia was the second most important determinant that was positively correlated with zone III classification, which includes patients lacking ≥3 of the diagnostic criteria for MwoA.

Our study aimed to contribute to new efforts to determine classification, from a unique point of view and by including the unique analysis of a large patient group diagnosed by a headache specialist at a tertiary centre. Moreover, while the performance of retrospective analysis in the dataset is a restriction in principle, it may be useful to recall that all the diagnoses were made after the fulfillment of basic requirements such as clinical inspection and medical examination.

CONCLUSION
==========

In cases that do not fulfill all the diagnostic criteria although they largely support the diagnosis of migraine in clinical terms, we believe that additional diagnostic characteristics (covariates), such as infantile colic, periodic vomiting, recurrent abdominal pain, the presence of motion sickness or vertigo, dizziness or osmophobia accompanying the pain, and a history of comorbid atopic disorder, are characteristics that merit discussion and consideration as additional diagnostic criteria (covariates) in preparing the final version of the ICHD-III.

The Turkish Headache Database system is an official system of the Turkish Headache Study Group. It has been compiled by Aynur Ozge MD since 2004 and is partially supported by the Turkish Neurology Society. All the authors contributed equally to the present study.
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###### 

International Classification of Headache Disorders-III beta criteria for diagnosing migraine without aura (1.1) ([@b11-prm-20-e1])

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  At least five attacks fulfilling criteria B through DHeadache attacks lasting 4 h to 72 h (untreated or unsuccessfully treated)Headache with at least two of the following characteristics: Unilateral locationPulsating qualityModerate to severe painAggravation by or causing avoidance of routine physical activity (eg, walking or climbing stairs)During headache at least one of the following: Nausea and/or vomitingPhotophobia and phonophobiaNot attributed to another disorder
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Diagnostic value of clinical characteristics included in International Classification of Headache Disorders-III beta-based diagnostic criteria

                                                              **Zone I (n=546)**   **Zone II (n=327)**     **Zone III (n=141)**                                                                                         
  ----------------------------------------------------------- -------------------- ----------------------- ---------------------- ------------ ---------------------- ------------- ------------ ---------------------- -------------
  Lasting 4 h to 72 h                                         455 (83.3)           1.560 (1.180--2.062)    **0.002**              212 (64.8)   0.355 (0.268--0.471)   **\<0.001**   41 (41.0)    0.150 (0.098--0.229)   **\<0.001**
  Severity of ≥5^[†](#tfn3-prm-20-e1){ref-type="table-fn"}^   544 (99.6)           3.565 (0.778--16.335)   0.138                  321 (98.2)   0.326 (0.104--1.016)   0.084         91 (95.8)    0.150 (0.044--0.506)   **0.008**
  Pulsating quality                                           492 (90.1)           4.096 (2.981--5.627)    **\<0.001**            162 (49.5)   0.157 (0.119--0.207)   **\<0.001**   52 (36.9)    0.127 (0.088--0.185)   **\<0.001**
  Unilateral location                                         168 (30.8)           0.431 (0.343--0.541)    **\<0.001**            40 (12.2)    0.127 (0.089--0.180)   **\<0.001**   25 (17.7)    0.256 (0.164--0.401)   **\<0.001**
  Nausea and/or vomiting                                      506 (92.7)           2.300 (1.583--3.342)    **\<0.001**            257 (78.6)   0.374 (0.267--0.524)   **\<0.001**   85 (60.3)    0.150 (0.101--0.221)   **\<0.001**
  Photophobia and/or phonophobia                              540 (98.9)           4.865 (2.054--11.524)   **\<0.001**            310 (94.8)   0.561 (0.307--1.028)   0.083         116 (82.3)   0.089 (0.049--0.162)   **\<0.001**

Bolded values indicate statistical significance.

*The patients meeting all of the criteria of the International Classification of Headache Disorders-III beta (n=351) were classified as having full migraine without aura while if they failed to meet one two or* ≥*3 of the criteria for the diagnostic gold standard they were classified as being in the grey diagnostic zones of zone I, zone II or zone III, respectively;*

Visual analogue scale score of pain severity

###### 

Diagnostic value of sex and medical history in the diagnosis full migraine without aura (MWoA) and grey zones I through III

                      **Full MwoA (n=351[\*](#tfn5-prm-20-e1){ref-type="table-fn"})**   **Zone I (n=546[\*](#tfn5-prm-20-e1){ref-type="table-fn"})**   **Zone II (n=327[\*](#tfn5-prm-20-e1){ref-type="table-fn"})**   **Zone III (n=141[\*](#tfn5-prm-20-e1){ref-type="table-fn"})**   **P**
  ------------------- ----------------------------------------------------------------- -------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------- -------------
  Sex                                                                                                                                                                                                                                                                                   
    Male              35 (10)                                                           61 (11.3)                                                      45 (13.9)                                                       21 (15.8)                                                        0.217
    Female            314 (90)                                                          480 (88.7)                                                     279 (86.1)                                                      112 (84.2)                                                       
  Premature birth                                                                                                                                                                                                                                                                       
    Absent            57 (90.5)                                                         106 (90.6)                                                     73 (93.6)                                                       25 (96.2)                                                        0.713
    Present           6 (9.5)                                                           11 (9.4)                                                       5 (6.4)                                                         1 (3.8)                                                          
  Infantile colic                                                                                                                                                                                                                                                                       
    Absent            59 (93.7)                                                         102 (87.2)                                                     75 (96.2)                                                       26 (100)                                                         **0.041**
    Present           4 (6.3)                                                           **15 (12.8)**                                                  3 (3.8)                                                         0 (0.0)                                                          
  Periodic vomiting                                                                                                                                                                                                                                                                     
    Absent            262 (75.9)                                                        428 (80.5)                                                     263 (81.2)                                                      121 (87.1)                                                       **0.041**
    Present           **83 (24.1)**                                                     104 (19.5)                                                     61 (18.8)                                                       18 (12.9)                                                        
  Abdominal pain                                                                                                                                                                                                                                                                        
    Absent            230 (65.5)                                                        387 (70.9)                                                     254 (77.7)                                                      127 (86.5)                                                       **\<0.001**
    Present           **121 (34.5)**                                                    159 (29.1)                                                     73 (22.3)                                                       19 (13.5)                                                        
  Allergy                                                                                                                                                                                                                                                                               
    Absent            194 (55.3)                                                        292 (53.5)                                                     193 (59.0)                                                      82 (58.2)                                                        0.404
    Present           157 (44.7)                                                        254 (46.5)                                                     134 (41.0)                                                      59 (41.8)                                                        

Data presented as n (%) unless otherwise indicated. Bolded values indicate statistical significance.

The sum of patient numbers is lower for some variables because of missing data

###### 

Diagnostic value of some triggers in the diagnosis of full migraine without aura (MWoA) and the grey zones I to III

                       **Full MwoA (n=351[\*](#tfn7-prm-20-e1){ref-type="table-fn"})**   **Zone I (n=546[\*](#tfn7-prm-20-e1){ref-type="table-fn"})**   **Zone II (n=327[\*](#tfn7-prm-20-e1){ref-type="table-fn"})**   **Zone III (n=141[\*](#tfn7-prm-20-e1){ref-type="table-fn"})**   **P**
  -------------------- ----------------------------------------------------------------- -------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------- -------------
  Emotional distress                                                                                                                                                                                                                                                                     
    Absent             7 (2.0)                                                           13 (2.4)                                                       23 (7.1)                                                        30 (21.4)                                                        **\<0.001**
  Present              **344 (98.0)**                                                    531 (97.6)                                                     301 (92.9)                                                      110 (78.6)                                                       
  Physical activity                                                                                                                                                                                                                                                                      
    Absent             67 (19.1)                                                         94 (17.3)                                                      55 (17)                                                         23 (16.4)                                                        0.851
    Present            284 (80.9)                                                        450 (82.7)                                                     269 (83)                                                        117 (83.6)                                                       
  Menstrual factors                                                                                                                                                                                                                                                                      
    Absent             147 (46.8)                                                        198 (41.9)                                                     129 (48.9)                                                      58 (55.2)                                                        **0.050**
    Present            167 (53.2)                                                        **275 (58.1)**                                                 135 (51.1)                                                      47 (44.8)                                                        
  Seasonal factors                                                                                                                                                                                                                                                                       
    Absent             184 (53.5)                                                        306 (57.1)                                                     178 (56.2)                                                      81 (58.7)                                                        0.672
    Present            160 (46.5)                                                        230 (42.9)                                                     139 (43.8)                                                      57 (41.3)                                                        
  Fasting                                                                                                                                                                                                                                                                                
    Absent             98 (27.9)                                                         153 (28.1)                                                     89 (27.5)                                                       46 (23.9)                                                        0.667
    Present            253 (72.1)                                                        391 (71.9)                                                     235 (72.5)                                                      94 (67.1)                                                        

Data presented as n (%) unless otherwise indicated.

The sum of patient numbers was lower for some variables because of missing data. Bolded values indicate statistical significance

###### 

Diagnostic value of some associated factors for the diagnosis of full migraine without aura (MWoA) and the grey zones I to III

                         **Full MwoA (n=351[\*](#tfn9-prm-20-e1){ref-type="table-fn"})**   **Zone I (n=546[\*](#tfn9-prm-20-e1){ref-type="table-fn"})**   **Zone II (n=327[\*](#tfn9-prm-20-e1){ref-type="table-fn"})**   **Zone III (n=141[\*](#tfn9-prm-20-e1){ref-type="table-fn"})**   **P**
  ---------------------- ----------------------------------------------------------------- -------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------- -------------
  Motion sickness                                                                                                                                                                                                                                                                          
  Absent                 148 (42.2)                                                        270 (49.5)                                                     170 (52.0)                                                      76 (53.9)                                                        **0.028**
  Present                **203 (57.8)**                                                    276 (50.5)                                                     157 (48.0)                                                      65 (46.1)                                                        
  Dizziness                                                                                                                                                                                                                                                                                
  Absent                 110 (31.3)                                                        169 (31)                                                       137 (41.9)                                                      83 (58.9)                                                        **\<0.001**
  Present                241 (68.7)                                                        **377 (69.0)**                                                 190 (58.1)                                                      58 (41.1)                                                        
  Vertigo                                                                                                                                                                                                                                                                                  
  Absent                 185 (52.7)                                                        287 (52.6)                                                     173 (52.9)                                                      91 (64.5)                                                        0.067
  Present                166 (47.3)                                                        259 (47.4)                                                     154 (47.1)                                                      50 (35.5)                                                        
  Osmophobia                                                                                                                                                                                                                                                                               
  Absent                 80 (23.1)                                                         151 (28.3)                                                     120 (37.4)                                                      81 (57.4)                                                        **\<0.001**
  Present                **266 (76.9)**                                                    383 (71.7)                                                     201 (61.6)                                                      60 (42.6)                                                        
  Allodynia                                                                                                                                                                                                                                                                                
  Absent                 169 (48.7)                                                        267 (50.3)                                                     179 (56.1)                                                      72 (59.0)                                                        0.082
  Present                178 (51.3)                                                        264 (49.7)                                                     140 (43.9)                                                      50 (41.0)                                                        
  Sleep irregularities                                                                                                                                                                                                                                                                     
  Absent                 83 (23.6)                                                         158 (28.9)                                                     131 (40.0)                                                      76 (53.9)                                                        **\<0.001**
  Present                **268 (76.4)**                                                    388 (71.1)                                                     196 (60.0)                                                      65 (46.1)                                                        

Data presented as n (%) unless otherwise indicated.

The sum of patient numbers was lower for some variables because of missing data. Bolded values indicate statistical significance

###### 

Rank of significance among covariates (P value in univariate analysis \[Pu\] ≤0.20) as determinant in the diagnosis of full migraine without aura (MWoA) and the grey zones

                                                                                **Pu ≤0.20**                                                                  **Pu \>0.20**                                                                                 
  ----------------------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------ ------------------------------- ------------------------------ ----------------------------------------------------------------------------------------------------------------------
  Full MwoA                                                                     Sleep irregularities (OR 1.596)[\*](#tfn10-prm-20-e1){ref-type="table-fn"}    Osmophobia (OR 1.348)          Emotional distress (OR 1.263)                                  Atopic disorders; infantile colic; physical activity; vertigo; menstrual factors; seasonal factors; fasting
  Periodic vomiting (OR 1.464)^[†](#tfn11-prm-20-e1){ref-type="table-fn"}^      Motion sickness (OR 1.237)                                                    Abdominal pain (OR 1.083)                                                                     
  Allodynia (OR 0.647)                                                                                                                                                                                                                                      
  Dizziness (OR 1.045)                                                                                                                                                                                                                                      
  Zone I                                                                        Infantile colic (OR 5.111)^[†](#tfn11-prm-20-e1){ref-type="table-fn"}^        Menstrual factors (OR 1.669)   Dizziness (OR 1.299)            Atopic disorders (OR 0.931)    Motion sickness; periodic vomiting; abdominal pain; physical activity; vertigo; seasonal factors; fasting; allodynia
  Sleep irregularities (OR 0.839)                                               Osmophobia (OR 1.027)                                                                                                                                                       
  Zone II                                                                       Sleep irregularities (OR 0.732)^[†](#tfn11-prm-20-e1){ref-type="table-fn"}^   Abdominal pain (OR 0.742)      Atopic disorders (OR 0.918)     Allodynia (OR 0.983)           Periodic vomiting; infantile colic; physical activity; vertigo; menstrual factors; seasonal factors; fasting
  Dizziness (OR 0.864)                                                          Motion sickness (OR 1.106)                                                                                                                                                  
  Osmophobia (OR 0.863)                                                                                                                                                                                                                                     
  Zone III                                                                      Osmophobia (OR 0.385)[\*](#tfn10-prm-20-e1){ref-type="table-fn"}              Periodic vomiting (OR 0.592)   Motion sickness (OR 1.188)      Menstrual factors (OR 0.995)   Atopic disorders; infantile colic; physical activity; seasonal factors; fasting
  Sleep irregularities (OR 0.642)^[†](#tfn11-prm-20-e1){ref-type="table-fn"}^   Abdominal pain (OR 0.584)                                                     Vertigo (OR 1.137)                                                                            
  Dizziness (OR 0.793)                                                                                                                                                                                                                                      
  Allodynia (OR 1.290)                                                                                                                                                                                                                                      

More commonly observed in male patients;

More commonly observed in female patients. Pm P value in multivariate analysis
